Takeda Pacific

Takeda Pacific (TP), is an international business consulting firm that is focused on facilitating business development projects. The business projects may involve European, Japanese, Asian and North American Life Science or High Technology companies. Since its founding in 1992, TP has reviewed or analyzed over 2,200 Life Science and Technology firms for its clients. TP has also developed an on-line database of over 300 contacts within Japanese and Asian Life Science companies. TP actively corresponds with US, European, Japanese and Asian companies involved in biopharmaceutical, biomedical, bio-agricultural research & development. In addition, this company list includes extensive contacts in leading High Technology IT firms.

 Takeda Pacific
 

List of reports from Takeda Pacific

Personalized Medicine: Companies, Trends and World Market
4/1/2012 | published by: Takeda Pacific
... report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Many people already know about DNA, genes and the ...  |  more...
$2,895.00
Next Generation Sequencing: Opportunities, Trends and World Market
5/1/2011 | published by: Takeda Pacific
... sequencing drops to $1,000 or less, scientists will be able sequence human genomes at the massive scale needed to better understand human variation and help open the gateway to personalized medicine. New NGS markets in ...  |  more...
$2,595.00
Epigenetics: Tools, Diagnostics, Drugs and World Market
8/1/2010 | published by: Takeda Pacific
... market segments such life science research tools, diagnostics and therapeutics. Many people already know about DNA, genes and the human genome. The DNA code defines the structure of who we are, our potential health and ...  |  more...
$2,195.00
Biomarkers, Tests and Trends for Drug R&D
2/1/2010 | published by: Takeda Pacific
... tools & technologies, products and R&D services. This report provides a detailed outlook of the market for biomarkers and related genomic, proteomic, or other tests used in drug R&D programs. The research report also touches ...  |  more...
$2,195.00
Biochips for Life Science Research, Diagnostics and Drug R&D
8/1/2009 | published by: Takeda Pacific
... research products and services involve technologies that scientists use to detect and analyze genetic, protein, or related material such as DNA, RNA, proteins, antibodies, stem cells, tissues, biomarkers and so on. This study takes into ...  |  more...
$2,495.00
Commercializing Molecular Diagnostics: Products,Services,Companies and Global Market
7/1/2008 | published by: Takeda Pacific
... biomarkers. The detailed study shows that molecular diagnostic companies are expecting continued strong growth. Takeda Pacific’s report shows the major areas of this dynamic market landscape. This report shows various views of this growing multi-billion ...  |  more...
$2,595.00
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
7/1/2007 | published by: Takeda Pacific
... Prize was awarded to the two scientists that discovered this important biological effect. RNAi allows scientists to disrupt or silence the expression of a gene being studied. RNAi can also be used as a therapeutic ...  |  more...
$2,395.00
Biomarkers and Tests for Pharma/ Biotech R&D - Companies Products and WW Market, 2006-2011
6/1/2007 | published by: Takeda Pacific
... applications and technologies. The research analyzed the future direction of biomarkers and related ‘-omic’ or pharmacogenomic (PGx) tests used in drug R&D. This report estimates the worldwide market value and growth (CAGR) of biomarkers and ...  |  more...
$2,395.00
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices
9/1/2006 | published by: Takeda Pacific
... to show where they fit in the industry landscape. This study reviews the kinds of drug delivery systems that are being used by pharma, biotech or medical device companies. The report discusses the broad range ...  |  more...
$1,995.00
Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies, Products and WW Market, 2004-2009
7/1/2005 | published by: Takeda Pacific
... the market for genomic, metabolomic and protein biomarkers and the related tests. The tests are used as molecular diagnostics and as pharmacogenomic assays to measure drug safety or effectiveness. Takeda Pacific’s report maps out the ...  |  more...
$2,195.00
Medical Biosensor Applications and Market to 2008 - Diabetes Management, Point-of-Care and Related Applications
5/1/2005 | published by: Takeda Pacific
... These applications include home blood glucose monitoring used for diabetes management and clinical biosensor applications including Point-of-Care-Testing devices, IV diagnostics and related applications. The surge in obesity and the disturbing growth rate of diabetes in ...  |  more...
$1,995.00
Prescription Drugs: Global Outlook to 2008
10/1/2004 | published by: Takeda Pacific
... activities including alliances, disease demographics to target major diseases, distribution channels and market trends. The research study shows that companies are facing challenging times ahead as drug patent expirations approach and lists patent expirations to ...  |  more...
$1,995.00
Nanotechnology and MEMS 2003: The Race to Commercialize the Ultra-Small
8/1/2003 | published by: Takeda Pacific
... nanotechnology R&D the NEXT BIG THING! The excitement about making ultra-small structures as a result of nanoscience R&D opens a whole world of potential commercial applications. Experts at the US National Science Foundation have suggested ...  |  more...
$1,695.00
Life Science Tools and Technologies for Bio-Pharma R&D - Instruments, Tech Platforms, Informatics and Market
3/1/2003 | published by: Takeda Pacific
... offers readers a detailed overview of the size and shape of the life science tools and techs market and what the products can do to facilitate the advancement of pharmaceutical and biotech drug R&D programs. ...  |  more...
$1,695.00
The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market
7/1/2002 | published by: Takeda Pacific
... thing as bio-IT. Companies involved in this interesting industry have made it possible for several genomics companies to sequence sections of the human genome as well as do work in proteomics. The bio-IT market is ...  |  more...
Buy by the section  |  Search inside this report
$1,995.00
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!